ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00251498
Recruitment Status : Completed
First Posted : November 10, 2005
Last Update Posted : August 21, 2008
Sponsor:
Collaborator:
Bristol-Myers Squibb
Information provided by:
Veeda Oncology

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : October 2007